"Lymphocyte Activation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION.
Descriptor ID |
D008213
|
MeSH Number(s) |
E01.370.225.812.482 E05.200.812.482 E05.478.594.530 G12.450.050.400.545 G12.565
|
Concept/Terms |
Lymphocyte Activation- Lymphocyte Activation
- Activation, Lymphocyte
- Blast Transformation
- Blastogenesis
- Lymphocyte Stimulation
- Stimulation, Lymphocyte
- Lymphocyte Transformation
- Transformation, Lymphoblast
- Lymphoblast Transformation
- Transformation, Blast
- Transformation, Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Lymphocyte Activation".
Below are MeSH descriptors whose meaning is more specific than "Lymphocyte Activation".
This graph shows the total number of publications written about "Lymphocyte Activation" by people in this website by year, and whether "Lymphocyte Activation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 2 | 1 | 3 |
1997 | 0 | 2 | 2 |
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2001 | 0 | 2 | 2 |
2003 | 1 | 0 | 1 |
2004 | 0 | 2 | 2 |
2006 | 0 | 2 | 2 |
2007 | 1 | 0 | 1 |
2008 | 1 | 2 | 3 |
2009 | 0 | 2 | 2 |
2010 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2013 | 3 | 6 | 9 |
2014 | 0 | 2 | 2 |
2015 | 1 | 0 | 1 |
2016 | 3 | 0 | 3 |
2017 | 0 | 2 | 2 |
2018 | 1 | 1 | 2 |
2019 | 0 | 2 | 2 |
2020 | 0 | 2 | 2 |
2021 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphocyte Activation" by people in Profiles.
-
Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022 02 03; 185(3):493-512.e25.
-
SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function. Eur J Immunol. 2021 11; 51(11):2651-2664.
-
Flow Cytometric Characterization of Human Antigen-Reactive T-Helper Cells. Methods Mol Biol. 2021; 2285:141-152.
-
Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19. Immunity. 2020 12 15; 53(6):1258-1271.e5.
-
CRELD1 modulates homeostasis of the immune system in mice and humans. Nat Immunol. 2020 12; 21(12):1517-1527.
-
Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction. Immunity. 2019 05 21; 50(5):1232-1248.e14.
-
Expression of the Phosphatase Ppef2 Controls Survival and Function of CD8+ Dendritic Cells. Front Immunol. 2019; 10:222.
-
CD83 expression is essential for Treg cell differentiation and stability. JCI Insight. 2018 06 07; 3(11).
-
CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures. Front Immunol. 2018; 9:199.
-
Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL. J Immunother. 2017 Jul/Aug; 40(6):224-248.